Skip to content

new SARS-CoV-2 detection system (COVID-19)

Clinical evaluation of the SARS-CoV-2 detection system (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1032200025
Enrollment
50
Registered
2020-05-01
Start date
2020-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 patients COVID-19

Interventions

None listed

Sponsors

Watanabe Yoshiyuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with suspected new coronavirus infection (COVID-19)

Exclusion criteria

Exclusion criteria: 1 Patients who did not get consent to participate in this study 2 Patients who could not collect the samples required for this study 3 Patients judged to be inappropriate by the doctor in charge and the attending physician

Design outcomes

Primary

MeasureTime frame
Evaluate the positive match rate, negative match rate, and overall match rate of the test drug "new corona gene detection reagent" against the real-time RT-PCR method based on the National Institute of Infectious Diseases "Pathogen Detection Manual 2019-nCoV" .

Contacts

Public ContactYoshiyuki Watanabe

Kawasaki Rinko General Hospital

ponponta@marianna-u.ac.jp+81-44-233-9336

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026